Cargando…
Sodium–glucose cotransporter 2 inhibitors do not increase the risk of fractures in real‐world clinical practice in Korea: A national observational cohort study
AIMS/INTRODUCTION: This study aimed to determine whether sodium–glucose cotransporter 2 inhibitors (SGLT2i) were related to increased fracture risk in adults with type 2 diabetes compared with dipeptidyl peptidase‐4 inhibitors (DPP‐4i). MATERIALS AND METHODS: Between 1 May 2016 and 31 December 2018,...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153829/ https://www.ncbi.nlm.nih.gov/pubmed/35132815 http://dx.doi.org/10.1111/jdi.13768 |